Complete Genome Sequences of Three Multidrug-Resistant Clinical Isolates of Streptococcus pneumoniae Serotype 19A with Different Susceptibilities to the Myxobacterial Metabolite Carolacton

Jannik Donner; Boyke Bunk; Isabel Schober; Cathrin Spröer; Simone Bergmann; Michael Jarek; Jörg Overmann; Irene Wagner-Döbler

doi:10.1128/genomeA.01641-16

Complete Genome Sequences of Three Multidrug-Resistant Clinical Isolates of Streptococcus pneumoniae Serotype 19A with Different Susceptibilities to the Myxobacterial Metabolite Carolacton

Genome Announc. 2017 Feb 16;5(7):e01641-16. doi: 10.1128/genomeA.01641-16.

Authors

Jannik Donner¹, Boyke Bunk², Isabel Schober², Cathrin Spröer², Simone Bergmann³, Michael Jarek⁴, Jörg Overmann², Irene Wagner-Döbler⁵

Affiliations

¹ Department of Medical Microbiology, Research Group Microbial Communication, Helmholtz Centre for Infection Research, Braunschweig, Germany jannik.donner@helmholtz-hzi.de.
² Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany and German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Braunschweig, Germany.
³ Technische Universität Braunschweig, Institute of Microbiology, Braunschweig, Germany.
⁴ Genome Analytics, Helmholtz Centre for Infection Research, Braunschweig, Germany.
⁵ Department of Medical Microbiology, Research Group Microbial Communication, Helmholtz Centre for Infection Research, Braunschweig, Germany.

Abstract

The full-genome sequences of three drug- and multidrug-resistant Streptococcus pneumoniae clinical isolates of serotype 19A were determined by PacBio single-molecule real-time sequencing, in combination with Illumina MiSeq sequencing. A comparison to the genomes of other pneumococci indicates a high nucleotide sequence identity to strains Hungary19A-6 and TCH8431/19A.